Investors

Events and Presentations

Analyst Coverage

Corporate Governance

Investor Contacts & Alerts

News Releases

Aug 3, 2020

Evofem Biosciences' CEO Saundra Pelletier Named to PharmaVOICE100 - The Most Inspiring People in Life Sciences
Jul 23, 2020

Evofem Biosciences to Report Second Quarter 2020 Results and Provide Corporate Update on Tuesday, August 4, 2020

-- Conference Call Scheduled for 11:00 a.m. EDT --
Jul 15, 2020

Evofem Biosciences Announces Peer-Reviewed Publication of the Pivotal Phase 3 AMPOWER Study Results For Phexxi™ (lactic acid, citric acid and potassium bitartrate) in Contraception
Jul 1, 2020

Evofem Biosciences Issues Mid-Year 2020 Letter to Stockholders

- On-Track for September Launch of Phexxi™, the First FDA-Approved, Non-Hormonal, On-Demand Prescription Contraceptive Gel -
Jun 2, 2020

Evofem Announces Pricing of Approximately $100 Million Public Offering of Common Stock

Show per page